Clinical Trials
Closed
Phase
Accrual
25%
Published
SWOG Clinical Trial Number
S0526
Phase II Trial of Pemetrexed in Patients with Selected Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC)
Research Committee(s)
Lung Cancer
Activated
07-01-2006
Closed
10-01-2008
Closed
Phase
Accrual
91%
Published
SWOG Clinical Trial Number
S0605
A Phase II Study of Lenalidomide (Revlimid®) (NSC-703813) for Previously Untreated Non-M3, Deletion 5q Acute Myeloid Leukemia (AML) in Patients Age 60 or Older Who Decline Remission Induction Chemotherapy
Research Committee(s)
Leukemia
Activated
06-15-2006
Closed
07-01-2010
Closed
Phase
Accrual
16%
Published
SWOG Clinical Trial Number
S0533
A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Addition of Bevacizumab (NSC-704865) in Three Cohorts of Patients with Inoperable Locally Advanced Stage III Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
06-15-2006
Closed
03-01-2010
Closed
Phase
Accrual
0%
SWOG Clinical Trial Number
S0308
A Phase III Randomized, Multicentered Non-Inferiority Trial Evaluating the Efficacy of Oral Ibandronate versus Intravenous Zoledronate in the Reduction of Skeletal-Related Events in Patients with Metastatic Breast Cancer
Research Committee(s)
Breast Cancer
Activated
05-15-2006
Closed
06-08-2006
Closed
Phase
Accrual
9%
SWOG Clinical Trial Number
S0425
Neoadjuvant Chemoradiation Therapy with Oxaliplatin and Capecitabine for Patients with Surgically Resectable Gastric Cancer: A Pilot Phase II Trial with Molecular Correlates
Research Committee(s)
Gastrointestinal Cancer
Activated
05-01-2006
Closed
01-15-2008
Closed
Phase
Accrual
95%
Published
SWOG Clinical Trial Number
S0618
Phase II Evaluation of E7389 (NSC-707389) in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
Research Committee(s)
Head and Neck Cancer
Activated
05-01-2006
Closed
01-01-2008
Closed
Phase
Accrual
40%
Published
SWOG Clinical Trial Number
S0429
A Pilot (Phase I) Study of Weekly Docetaxel and Cetuximab Chemoradiation for Poor Risk Stage III Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
04-01-2006
Closed
08-15-2009
Closed
Phase
Accrual
58%
Published
SWOG Clinical Trial Number
S0434
A Phase II Trial of BAY 43-9006 (Sorafenib) (NSC-724772) in Patients with Relapsing or Resistant Multiple Myeloma
Research Committee(s)
Myeloma
Activated
03-15-2006
Closed
Phase
Accrual
56%
Published
SWOG Clinical Trial Number
S0512
Phase II Trial of BAY 43-9006 (Sorafenib; NSC-724772) in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma
Research Committee(s)
Melanoma
Activated
03-15-2006
Closed
01-01-2009
ClinicalTrials.gov Registry Number
NCT00329641
Closed
Phase
Accrual
68%
Published
SWOG Clinical Trial Number
S0505
Phase II Trial of BAY 43-9006 (NSC #724772) in Advanced Soft Tissue Sarcomas
Research Committee(s)
Sarcoma
Activated
03-01-2006
Closed
Phase
Accrual
55%
Published
SWOG Clinical Trial Number
S0520
Phase II Study of PXD101 (NSC-726630) in Relapsed and Refractory Aggressive B-Cell Lymphomas
Research Committee(s)
Lymphoma
Activated
01-01-2006
Closed
05-01-2009
Closed
Phase
Accrual
2%
SWOG Clinical Trial Number
S0427
A Phase III Trial of Standard Fractionation Radiation and Concurrent Single Agent Cisplatin, with and without Docetaxel, Cisplatin, and 5-Fluorouracil Induction Chemotherapy, in Patients with Advanced Oropharyngeal Squamous Cell Cancer
Research Committee(s)
Head and Neck Cancer
Activated
12-15-2005
Closed
01-10-2007
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S0307
Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer
Research Committee(s)
Breast Cancer
Activated
11-15-2005
Closed
02-01-2010
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0433
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0509
A Phase II Study of Novel Oral Anti-Angiogenic Agent AZD2171 (NSC-732208) in Malignant Pleural Mesothelioma
Research Committee(s)
Lung Cancer
Activated
11-01-2005
Closed
04-01-2008
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S0410
Tandem Autologous Stem Cell Transplantation For Patients With Primary Progressive or Recurrent Hodgkin's Disease (A BMT Study), Phase II
Research Committee(s)
Lymphoma
Activated
10-15-2005
Closed
02-01-2009
Closed
Phase
Accrual
72%
Published
SWOG Clinical Trial Number
S0514
Phase II Study of BAY 43-9006 (NSC #724772) as Single Agent in Unresectable or Metastatic Gallbladder Carcinoma and Cholangiocarcinoma
Research Committee(s)
Gastrointestinal Cancer
Activated
10-01-2005
Closed
01-01-2007
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S0424
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Research Committee(s)
Lung Cancer
Molecular Epidemiology
Activated
10-01-2005
Closed
03-15-2011
Closed
Phase
Accrual
0%
SWOG Clinical Trial Number
S0511
A Phase II Study of Goserelin Plus Anastrozole for the Treatment of Male Patients With Hormone-Receptor Positive Metastatic or Recurrent Breast Cancer"
Research Committee(s)
Breast Cancer
Activated
09-15-2005
Closed
01-10-2007
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0350
Phase II Trial of Cisplatin Plus Etoposide Plus Gemcitabine Plus Solumedrol (PEGS) in Peripheral T-Cell Non-Hodgkin's Lymphoma
Research Committee(s)
Lymphoma
Activated
09-15-2005
Closed
12-01-2010